This is an exclusive BHB+ story
Serial behavioral health buyers, including LifeStance Health (Nasdaq: LFST), ARC Health and Beacon Behavioral Partners, have shifted gears in acquisition strategies over the last five years.
Characteristics that marked important acquisitions in 2021 and 2022 for these players have transitioned from a focus on pure growth to fit, integration and sustainability.
LifeStance Health, as one of the largest outpatient behavioral health operators in the U.S., had completed 90 acquisitions by the end of 2022. Following that, the company slowed its M&A strategy to focus on cohesion across its many integration efforts. But during its first-quarter earnings call earlier this month, Dave Bourdon, LifeStance’s CEO said the company is returning to its M&A execution with a focus on tuck-in deals and already has a strong pipeline of potential targets.
“We learned a lot during our initial M&A period,” Dan Ferris, Chief Growth Officer at LifeStance, told Behavioral Health Business. “I would say we are much more precise on what we’re looking for and how we’re going to integrate, and at the pace that we’re going to integrate at, and we’ve spent a lot of time over the last few years during this pause in really making sure our foundation is rock solid.”
Now that LifeStance has a single operating model and a single electronic medical record (EMR) system, any new M&A activity will be integrated into that ecosystem with greater precision and speed than the company was capable of before, Ferris explained.
Next, the company will eye targets that expand its outpatient footprint, grow service lines like interventional psychiatry treatments such as transcranial magnetic stimulation (TMS) and ketamine, and are a clear culture and compliance fit.
“Culture fit is really critical,” Ferris said. “Oftentimes when you’re doing an M&A, part of what you’re buying is the team and the talent, and you have to make sure that the combined organizations will be able to retain the people who are part of the acquisition that you’re making.”
Culture and compliance fit at the core
Culture and compliance are emerging as important navigation points on buyers’ compasses to guide clear acquisition fits.
Particularly during a time when federal government audits are intensifying, and there is more scrutiny on fraud, waste and abuse across all sectors of healthcare, this matters even more than before, leaders at behavioral health platforms like ARC Health and Beacon Behavioral Partners agreed.
“The most successful partnerships are built on transparency, alignment, and maintaining a strong focus on clinical quality throughout the integration process,” Marcus Morosin, executive vice president of mergers and acquisitions at ARC Health, told BHB.
Both ARC Health and Beacon Behavioral Partners have had storied M&A trajectories over the last five years. ARC Health’s strategy from 2021 to 2023 prioritized roll-ups. The company, which was founded in 2021, ended its two-year buying spree with 18 mergers.
Most of Beacon Behavioral Partners’ dealmaking was clustered in 2025 when it purchased five independent providers to expand its footprint. With the acquisition of Carolina Psychiatry in March 2026, Beacon grew its operational footprint to nine states. From 2022 onward, its strategy has centered around more of an “add-on” focus.
Lessons learned from that period? Partner with good people who want to provide quality care, Todd Mudd, the senior vice president of business development at Beacon Behavioral Partners, told BHB.
“We focus on partnering with leading outpatient psychiatry practices that focus on med management, psychotherapy and TRD services such as Spravato and TMS,” Mudd said. “We complete substantial diligence to protect the partners and Beacon and ensure compliance and financial viability. We limit risk by partnering with successful practices that have a history of quality and strong growth.”
Going forward, Beacon will eye acquisitions to help it continue scaling in targeted markets across its service lines, Mudd said.
All three leaders at LifeStance, ARC Health and Beacon Behavioral underscored the importance of service-line specialization in 2026. This is in line with previous BHB reporting that cited as more and more players enter the behavioral health sector, starting small and going niche with specializations may be the new recipe for success.
What buyers are swiping left on
Of course, with a shifting market and shifting buyer priorities, there’s also a list of what makes an unattractive target – or as the kids would say, “what makes you swipe left.”
No matter how compelling the growth story, there are certain things that LifeStance, ARC Health and Beacon Behavioral leaders said they would never buy. What they all have in common: companies with weak compliance, low or no scalability potential, and companies that will not fit cleanly in with existing operational models.
“We would never seriously look into a business or service line that is limited in its ability to scale and utilize growth levers,” Mudd said.
Beacon Behavioral also tends to stay in its lane when considering possible acquisitions, Mudd said. Which is something LifeStance is also focusing on: only acquiring within its outpatient mental health sector.
In addition to being more discerning and precise in its acquisition targets than in the past, Ferris explained that among the things LifeStance will likely never look to acquire are technologies, EMR platforms, software, etc. That’s where the company prefers to partner and license rather than own it itself. What’s also off the table for the company is entering into inpatient or residential care, he said.
“We ask ourselves, ‘What can we be the best in the world at doing?’ And we believe focus is important, and so we’re going to stay within outpatient mental health,” Ferris said. “We have referral partners in higher levels of care that we will fall out to and receive referrals into. So, we feel like we can partner with the broader ecosystem, but we’ll stay focused on the outpatient health ecosystem.”
While these buyers are becoming more selective in their dealmaking than they were a few years ago, all three are poised for continued growth via acquisition activity. If the timing and alignment are a match, they’ll definitely swipe right.